mRNA For Lung Cancer

Will it work?

  • Yes

    Votes: 5 33.3%

  • No

    Votes: 2 13.3%

  • Wait and see

    Votes: 8 53.3%
  • Total voters
    15
  • Poll closed .
volpri said:
Then too we have many times in the past were scientist where wrong in their conclusions and changed their minds.
More...
Absolutely, and that is the beauty of science.

We can be wrong if new evidence emerges and proves that the old hypothesis is no longer correct, we are willing to face the truth and admit we are wrong.

There is no shame to be wrong sometimes. That is how we move forward.
 
volpri said:
There is no $$$$ to be made from ivermectin but many $$$ to be made from covid vax and chemo…etc
Do we really think the scientific world and Pharmaceuticals are going to affirm some that they can’t make $$$$ on?
More...
If ivermectin works against lung cancer, Merck will make billions from it.

How? Just like they are making billions out of their PD-L1 inhibitor by tweaking the compound to make it more effective and less side effects.

The hypothesis is ivermectin inhibits the PAK1 cancer pathway and if so they can tweak it to make it more effective and since it is already FDA approved for safety, it will cost them a lot less to develop...

There are many other examples, one is taxol, one of the most effective chemo drugs, derived from the bark of the pacific yew tree.
 
stonedinvestor said:
Hello.

The main point here regarding lung cancer is scary. We have not been getting the whole truth. Around the world, in polluted places Lung cancer rates are skyrocketing in people WHO HAVE NEVER SMOKED<--- This is a new and startling problem. Micro plastics in the air I assume forever chemicals whatever the hell is breathed is causing the cancer.. this is a bridge too far.

This dovetails with younger folks getting prostate cancer and such we have to assume from the food we eat.

Cancer may be finding new ways to kill us right now. This trial, this drug, is vitally important.

BNT116.

The trial in Britain is being expanded.

According to information from the National Institutes of Health’s ClinicalTrials.govwebsite, potential participants in the trial of BNT166 are being recruited in the D.C. region at Baltimore’s Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and NEXT Virginia in Fairfax.

BioNTech BNT116 is very promising and is fully owned by the co.

In phase 1 BioNTech BNT221 for melanoma & solid tumor is fully owned. This is a cell therapy.
Vs MRNA but is their some combo down the road?

So one investing idea is a small player in cell therapy that BNTX is partnered with.... I think this can get to $9 or perhaps will be swallowed up by BNTX.

Watch->AUTL Autolus Therapeutics plc

$3.92- 4:00 PM 08/28/24

~si
More...
When someone handed you a lemon, you make lemonade.

I have traded many biotech startups.

It is tradable because the failure rate is so high, the option prices reflected that.

If one has some knowledge on the underlying science and can determine that Wall Streets' general view is off for that particular company, one can make a good living.
 
You must log in or register to reply here.
Back
Top